PET-Technology, a project company of Russian nanotech giant RUSNANO, has started construction of a plant to make radiopharmaceuticals for positron-emission tomography in the city of Elets, Lipetsk region, ÐÎÑÍÀÍÎ reports.
The plant is a part of RUSNANO’s project to set up a chain of centers of positron-emission and computer tomography in Russia. As Marchmont reported earlier, total project budget is $80m, including RUSNANO’s $40m contribution (see news of May 21, 2012).
The center in Elets will produce diagnostics radiopharmaceuticals for tomographic examinations in the regional of the Central Federal District. Production is scheduled to be launched in 2013. Project annual capacity of the complex is 100,000 doses. Under plans, the center will have a radiochemical lab and quality control lab, as well as particle accelerator (cyclotrone).
Positron-emission tomography is an efficient method to detect oncology, cardiology, and neurology diseases. The method is based on selective absorption of radiopharmaceuticals by tumor tissues and highly metabolic tissues. The method’s most significant advantage is that it allows to diagnose a disease at early stages and thus make treatment easier and more effective.